Clinical trial / 2010
Cinnamon supplementation (2g daily for 12 weeks) significantly reduced HbA1c and blood pressure in poorly controlled type 2 diabetes patients.
Fifty-eight patients with type 2 diabetes and HbA1c > 7% were randomized to receive either 2g of cinnamon or placebo daily for 12 weeks. Compared with placebo, the cinnamon group showed significant reductions in mean HbA1c (8.22% to 7.86% vs. 8.55% to 8.68%, P<0.005), systolic blood pressure (132.6 to 129.2 mmHg vs. 134.5 to 134.9 mmHg, P<0.001), and diastolic blood pressure (85.2 to 80.2 mmHg vs. 86.8 to 86.1 mmHg, P<0.001). Within the cinnamon group, fasting plasma glucose, waist circumference, and BMI decreased significantly from baseline, but differences were not significant compared to placebo. No significant differences were observed in serum lipid profiles between or within groups.
- Study type
- Randomized, placebo-controlled, double-blind trial
- Who was studied
- 58 type 2 diabetic patients (25 males, 33 females, aged 54.9 ± 9.8) treated only with hypoglycemic agents and HbA1c > 7%
- What was measured
- HbA1c, blood pressure, lipid profiles, fasting plasma glucose, waist circumference, and BMI
THE PAPER
Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial.
Akilen R, Tsiami A, Devendra D, Robinson N. Diabet Med, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.